Abstract
BackgroundThe benefit of a “diagnosis” of pre-diabetes in very elderly patients is debated. How clinicians manage pre-diabetic blood results in these patients is unknown. This study aims to understand how clinicians are “diagnosing” older patients with pre-diabetic blood parameters.MethodsSemi-structured interviews and focus groups with health care staff (24 total participants) were conducted in the north of England. Interviews and focus groups were recorded, transcribed and analysed thematically. A grounded theory approach was taken with the theory of candidacy being used as a sensitising concept through which questions were framed and results interpreted.ResultsThere is a complex system of competing pressures that influence a clinician in deciding whether, and in what way, to inform a very elderly patient that they have pre-diabetes. The majority of clinicians adjust their management of pre-diabetes to the age and perceived risk/benefit for the patient. Whilst some clinicians choose not to inform certain patients of their blood results, many clinicians maintain, what could be seen as a somewhat paradoxical approach of labeling all older patients with pre-diabetes but downplaying the significance to the patient. The policy, organisational context, workload and professional constraints under which clinicians work, play a significant role in shaping how they deal with pre-diabetic blood results in the very elderly.ConclusionThere has been recent acknowledgement of how policy and organisational context frames decision-making, but there is a lack of evidence on how this influences uncertainty and dilemmas in decision-making in practice. These findings add further weight for the argument that treatment burden should be included in clinical guidelines.
Highlights
The benefit of a “diagnosis” of pre-diabetes in very elderly patients is debated
The risk of overdiagnosis should not take away from the risk of missing opportunities to identify pre-diabetes in those that may benefit from intervention and lifestyle change
There is limited benefit and potential harm in diagnosing and treating some very elderly patients, and the numbers of these patients who would fulfil the criteria for pre-diabetes is probably large
Summary
The benefit of a “diagnosis” of pre-diabetes in very elderly patients is debated. How clinicians manage pre-diabetic blood results in these patients is unknown. This study aims to understand how clinicians are “diagnosing” older patients with pre-diabetic blood parameters. Pre-diabetes is a term that encompasses three different biochemical abnormalities: raised HbA1c, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). England is currently in the process of a roll-out of a national diabetes prevention programme (DPP). The DPP national service specifications state that any patient over 18 with a pre-diabetic blood test result is eligible for the programme. It does not specify an upper age limit for entry
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have